UCT, in March 2018, implemented its research data management (RDM) policy to support effective data sharing and to address the need for data to be findable, accessible, interoperable and reusable (FAIR) to specific quality standards.
Last week (27 January – 1 February), ACDI delivered the first of a series of PhD Summer schools here at UCT. The summer school series is part of the University Staff Doctorate Programme (USDP) on ‘Climate risk, resilience, and sustainable development’.
The ACDI's collaborative project with the Western Cape government's departments of Agriculture and Environment & Development Planning was awarded top honours in last night's Public Service Excellence Awards.
Master’s in Development Policy and Practice students from the UCT’s Mandela School left Khayelitsha inspired on Tuesday, 29 January, after meeting various social entrepreneurs who have made a significant difference in their communities.
Lynne Coleman, Senior Lecturer at Cape Peninsula University of Technology, takes a look at recently published collection, Teaching in Extended Programmes in South Africa, which features reflections by ADP lecturers on classroom practices in extended programmes.
Is there a relationship between university world rankings and quality of teaching? What is the relationship between quality and addressing inequality at HEIs? A/Prof Suellen Shay reflects on these questions in this recent The Conversation article.
The Neuroscience Institute put out a Request for Applications in 2018 in order to encourage start-up collaborative grants, that could be converted into larger grants to sustain independent investigators. We are pleased to announce that 3 grants have been awarded.
Dr Ying Zhao’s MMed study is entitled “Improved treatment outcomes with bedaquiline when substituted for second-line injectable agents in multidrug resistant tuberculosis”. Her MMed is supervised by Dr Sean Wasserman and Professor Graeme Meintjes.
The University of Cape Town’s Drug Discovery and Development Centre (H3D), the African Academy of Sciences (AAS), Bill & Melinda Gates Foundation and Medicines for Malaria Venture (MMV) have committed funding for the discovery of new drugs for diseases endemic to Africa over the next two years.